Construcción y calibración del modelo

Statement of financial position

• Reduction in total assets, mainly due to a decrease in working capital and impairment charges in the Performance Polymers and Performance Chemicals segments

• Equity ratio below prior year, primarily due to net loss • Net financial liabilities above prior year at €1,731 million

Structure of the Statement of Financial Position

Dec. 31, 2012 Dec. 31, 2013 Change

€ million % € million % % Assets Non-current assets 3,747 49.8 3,592 52.7 (4.1) Current assets 3,772 50.2 3,219 47.3 (14.7) Total assets 7,519 100.0 6,811 100.0 (9.4) Equity and liabilities Equity (including non-controlling interests) 2,330 31.0 1,900 27.9 (18.5) Non-current liabilities 3,559 47.3 3,029 44.5 (14.9) Current liabilities 1,630 21.7 1,882 27.6 15.5 Total equity and liabilities 7,519 100.0 6,811 100.0 (9.4) 2012 figures restated

Structure of the statement of financial position Total assets of the LANXESS Group amounted to €6,811 million as of December 31, 2013, a decrease of €708 million, or 9.4%, on the prior-year figure. This was primarily due to the decline in near-cash assets, the reduc- tion of working capital and write-downs. The latter mainly impacted the Keltan Elastomers, High Performance Elastomers and Rubber Chemicals business units. The sum of depreciation, amortization and write-downs exceeded capital expenditures for property, plant and equipment. The ratio of non-current assets to total assets increased from 49.8% to 52.7%. On the equity and liabilities side, equity de- creased due to negative currency translation adjustments in other equity components and to the net loss recorded. At the end of 2013, the equity ratio was 27.9%, after 31.0% in the previous year.

Structure of the Statement of Financial Position – Assets

€ million

Non-current assets fell by €155 million, or 4.1%, to €3,592 million. Additions from capital expenditures for intangible assets and prop- erty, plant and equipment totaled €676 million, against the prior-year figure of €734 million. They were offset primarily by depreciation and amortization of €438 million, against €374 million in the previous year, and by write-downs on intangible assets and property, plant and equipment of €279 million, against €4 million in 2012. Cash outflows for purchases of property, plant, equipment and intangible assets, at €624 million, were below the prior-year figure of €696 mil- lion on account of our stringent project prioritization. The first-time full consolidation of LANXESS-TSRC (Nantong) Chemical Industrial Co., Ltd., Nantong, China, previously accounted for as an associate, and the first-time consolidation of PCTS Specialty Chemicals Pte. Ltd., Singapore, which was acquired in April 2013, led to additions in the mid-double-digit million euro range. The carrying amount of invest- ments accounted for using the equity method increased by €4 million

2012 2013 3,226366 2,369 533317 3,384363 2,644 797331 7,519 6,811

Intangible assets and property, plant and equipment Other non-current assets Inventories and receivables Cash and cash equivalents Other current assets

to €12 million. This change resulted mainly from the net-asset driven adjustment to the carrying amount of the interest in Currenta GmbH & Co. OHG, Leverkusen, Germany, and to the change in the accounting for LANXESS-TSRC (Nantong) Chemical Industrial Co., Ltd., Nantong, China, in the consolidated financial statements. By contrast, the decline in investments in other affiliated companies was mostly influenced by the fair-value remeasurement of the strategic minority interest in BioAmber Inc., Minneapolis, United States, in light of that company’s recent share performance. At €55 million, other non-current financial assets were substantially below the prior-year level, primarily due to the decrease in receivables associated with pension obligations. The ratio of non-current assets to total assets was 52.7%, up from 49.8% on December 31, 2012.

Current assets decreased by €553 million, or 14.7%, against the prior-year value of €3,772 million, to €3,219 million. The ratio of current assets to total assets declined to 47.3% from 50.2% in the previous year. On account of lower raw material prices and targeted inventory reductions, also supported by exchange rate development, inventories decreased by €228 million, or 14.9%, to €1,299 million. Days of sales in inventories (DSI) improved from 64.7 to 58.0. Trade receivables decreased by €47 million to €1,070 million against the previous year, mainly due to negative currency effects. Days of sales outstanding (DSO) were virtually unchanged at 47.8. Minimal portfolio effects from the acquisitions made during the reporting year had no significant influence on net working capital. Near-cash assets de- creased by €305 million to €106 million following the sale of shares in money market funds. Cash and cash equivalents rose by €41 million compared to the end of 2012, to €427 million. This development was also influenced by the sale of money market paper.

The LANXESS Group has significant internally generated intangible assets that are not reflected in the statement of financial position due to accounting rules. These include the brand equity of LANXESS and the value of other brands of the Group. A variety of measures was deployed in the reporting period to continually enhance these assets, which helped us to maintain our business units’ sound market positions. Our established relationships with customers and suppliers also con- stitute a significant intangible asset. These long-standing, trust-based partnerships with customers and suppliers, underpinned by consistent service quality, have made it possible for us to compete success- fully – also in a more challenging business environment. Our specific competence in technology and innovation, also a valuable asset, is rooted in our expertise in the areas of research and development and custom manufacturing. It enables us to generate added value for our customers.

31 Combined Management Report – Economic Report Statement of financial position and financial condition

The know-how and experience of our employees are central pillars of our corporate success. In addition, we have sophisticated production and business processes that create competitive advantages for us in the relevant markets.

Structure of the Statement of Financial Position – Equity and Liabilities

€ million

2012 figures restated

Equity, including non-controlling interests, amounted to €1,900 mil- lion, down from €2,330 million in the previous year. The equity ratio was 27.9% after 31.0% at the end of 2012. Prominent factors in the equity decrease were negative currency translation adjustments in other equity components and the net loss recorded. The dividend payout of €83 million to LANXESS AG stockholders in May 2013 also had an effect.

2012 2013 2,330 2,171 1,388 972 658 1,900 1,661 1,368 1,380502 7,519 6,811 Equity Non-current financial liabilities Other non-current liabilities Current financial liabilities Other current liabilities

Non-current liabilities decreased by €530 million to €3,029 million as of December 31, 2013. This resulted mainly from the other non- current financial liabilities, which were €518 million lower than the previous year at €1,649 million. The decrease was largely due to the reclassification into other current financial liabilities of the €500 million Eurobond maturing in April 2014. By contrast, provisions for pensions and other post-employment benefits increased by €50 million as against the end of 2012, to €943 million. This increase mainly related to the Advance program and additional vested rights established in the reporting period. Other long-term provisions decreased by a similar magnitude for reasons that include a decline in long-term personnel- related commitments. The ratio of non-current liabilities to total assets was 44.5%, slightly down from 47.3% at the end of 2012.

Current liabilities increased by a substantial €252 million, or 15.5%, to €1,882 million against December 31, 2012. This was largely the result of the aforementioned reclassification into other current finan- cial liabilities of the €500 million Eurobond. At €690 million, trade payables were down substantially on the €795 million reported at the end of 2012 due to a slight decrease in purchasing volumes and lower prices for our strategic raw materials. The increase in current liabilities was also curtailed by the decrease in other current provisions, primarily due to their utilization for bonus payments to employees for fiscal 2012 and to lower allocations in the reporting year. The ratio of current liabilities to total assets was 27.6% at December 31, 2013, compared with 21.7% at the end of 2012.

Net financial liabilities increased by €248 million from the previous year to €1,731 million. Cash outflows for capital expenditures, inter- est and dividends exceeded cash inflows from operating activities. The Group’s key ratios developed as follows:

Ratios

% 2009 2010 2011 2012 2013

Equity ratio Equity1)

Total assets 28.5 31.1 30.2 31.0 27.9

Non-current asset ratio Non-current assets

Total assets 47.0 48.3 50.7 49.8 52.7

Asset coverage I Equity1)

Non-current assets 60.7 64.3 59.4 62.2 52.9

Asset coverage II Equity1) _{and non-current liabilities}

Non-current assets 165.8 153.9 137.3 157.2 137.2 Funding structure Current liabilities

Total liabilities 30.9 37.2 43.5 31.4 38.3

Capital expenditures In 2013, capital expenditures for property, plant and equipment and intangible assets came to €676 million, com- pared with €734 million the year before, and led to cash outflows of €624 million (2012: €696 million). Depreciation and amortization totaled €717 million in the same period (2012: €378 million). This figure included €270 million in write-downs reported as exceptional items (2012: €2 million). Adjusted for these write-downs, capital expenditures in support of our growth strategy exceeded deprecia- tion and amortization by a substantial 51% (2012: 95%).

Cash Outflows for Capital Expenditures vs. Depreciation and Amortization

€ million

In the reporting year, capital expenditures focused on the following areas:

• construction of new facilities, expansion and maintenance of existing facilities;

• measures to increase plant availability;

• projects to improve plant safety, enhance quality and comply with environmental protection requirements.

Less than two-thirds of the capital expenditures in 2013 went toward expansion or efficiency improvement measures, while the rest went to maintain existing facilities. This underlines our goal of generat- ing further organic growth through investment, as described under “Earnings strategy” in the “Strategy” section of this combined man- agement report.

In regional terms, 34% of our capital expenditures in the reporting period were made in Germany, 20% in the EMEA region (excluding Germany), 7% in North America, 7% in Latin America and 32% in

2013 2012 2011 2010 2009 0 200 400 600 800 624 717 696 378 679 325 501 283 275 273

Depreciation and amortization Cash outflows for capital expenditures

Asia-Pacific. Capital expenditures in Germany mostly comprised our investments to increase capacities and modernize facilities in all segments, especially capacity improvements for the Advanced Industrial Intermediates business unit and the expansion of several plants for the High Performance Elastomers business unit. The con- tinued large share of capital expenditures made in the Asia-Pacific region in the reporting year is due primarily to the construction of a new production plant for high-performance neodymium-based performance butadiene rubber (Nd-PBR) for the Performance Buta- diene Rubbers business unit in Singapore and the construction of a new production plant for EPDM rubber for the Keltan Elastomers business unit in Changzou, China.

Cash Outflows for Capital Expenditures by Segment

€ million

In the Performance Polymers segment, capital expenditures amount- ed to €405 million (2012: €455 million), €385 million (2012: €434 million) of which were cash outflows. Depreciation and amor- tization amounted to €489 million (2012: €209 million). The major capital expenditures in this segment were made in the Performance Butadiene Rubbers business unit. Capital expenditures in the Ad- vanced Intermediates segment amounted to €113 million (2012: €104 million). Cash outflows came to €96 million (2012: €92 mil- lion), exceeding the depreciation and amortization of €77 million (2012: €67 million). This figure includes capital expenditures in the Advanced Industrial Intermediates business unit for expansion of the cresol plant in Leverkusen, Germany. In the Performance Chemi- cals segment, capital expenditures came to €117 million (2012: €139 million), €111 million (2012: €135 million) of which were cash outflows. Depreciation and amortization stood at €127 million (2012: €87 million). Key capital expenditures were the construc- tion of a new CO2 concentration unit in Newcastle, South Africa, for

the Leather business unit and the construction of a state-of-the-art plant for iron oxide red pigments in Ningbo, China, for the Inorganic Pigments business unit.

385 2012 96 111 32 624 2013 434 92 135 35 696 Performance Polymers Advanced Intermediates Performance Chemicals Reconciliation

33 Combined Management Report – Economic Report Statement of financial position and financial condition

The following table shows major capital expenditure projects in the LANXESS Group.

Selected Capital Expenditure Projects 2013

Segment Site Description

Performance Polymers

Butyl Rubber Singapore Construction of a new butyl rubber plant, start-up in the first quarter of 2013 Performance Butadiene Rubbers Singapore Construction of a new butadiene rubber plant, start-up in the first half of 2015 High Performance Elastomers Dormagen, Germany Expansion of production capacities for chloroprene rubbers

Keltan Elastomers Sittard-Geleen, Netherlands Investment to convert EPDM rubber production to the innovative Keltan® _ACE™

technology, completion in 2013

Keltan Elastomers Changzhou, China Construction of an EPDM rubber plant, start-up in 2015

High Performance Materials Porto Feliz, Brazil Construction of a new compounding plant for high-tech plastics, completion in 2014 High Performance Materials Antwerp, Belgium Expansion of glass fiber capacities

High Performance Materials Antwerp, Belgium Construction of a new polyamide plastics plant, completion in 2014

Advanced Intermediates

Advanced Industrial Intermediates Leverkusen, Germany Expansion of cresol production, completion mid-2013

Performance Chemicals

Rhein Chemie Porto Feliz, Brazil Construction of a plant for high-performance curing bladders, start-up in 2013 Rhein Chemie Lipetsk, Russia Construction of a new plant for rubber additives and release agents, start-up in 2013 Liquid Purification Technologies Leverkusen, Germany Construction of a production line for weakly acidic cation exchange resins,

completion mid-2014

Inorganic Pigments Ningbo, China Construction of a state-of-the-art production facility for iron oxide red pigments Leather Changzhou, China Construction of a new plant for leather chemicals, start-up in April 2013 Leather Newcastle, South Africa Construction of a CO2 concentration unit, start-up in the fourth quarter of 2013

Expansion of the Group portfolio Please see “Additions to the Group portfolio” in this combined management report for more information on the subsidiaries and affiliates added to our portfolio in fiscal 2013.